Serum visfatin, an adipokine positively associated with an adverse metabolic profile in obesity [27, 108, 299], exerts proliferative effects and induces resistance to chemotherapy in AML cells in vitro [218]. This evidence concerns the gene NAMPT and obesity due to melanocortin 4 receptor deficiency.